Brian K. Martin

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

Jason A. Regules, John H. Beigel, Kristopher Paolino et al. · New England Journal of Medicine · 2015 · 395 citations · Full text

Life Sciences, Infectious Diseases, Preventive Medicine +11

Induction of MHC Class I Expression by the MHC Class II Transactivator CIITA

Brian K. Martin, Keh-Chuang Chin, John C. Olsen et al. · Immunity · 1997 · 211 citations · Full text

Life Sciences, Immunology, Molecular Biology +11

Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity

Todd D. Armstrong, Virginia K. Clements, Brian K. Martin et al. · Proceedings of the National Academy of Sciences · 1997 · 168 citations

Life Sciences, Immunology, Oncology +17

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

D. Gray Heppner, Tracy Kemp, Brian K. Martin et al. · The Lancet Infectious Diseases · 2017 · 121 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Two Distinct Domains within CIITA Mediate Self-Association: Involvement of the GTP-Binding and Leucine-Rich Repeat Domains

Michael W. Linhoff, Jonathan A. Harton, Drew E. Cressman et al. · Molecular and Cellular Biology · 2001 · 95 citations · Full text

Life Sciences, Immunology, Molecular Biology +15